UPDATE 1-U.S. FDA clears version 2.0 of Abbott's low-cost glucose monitor
June 15, 2020 at 07:49 AM EDT
The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, FreeStyle Libre, helping the company build upon the success of its fastest-growing diabetes product.
